Prognostication Scale for Resistant Arterial Hypertension Development among Elderly and Senile Patients

V.A. Skybchyk, S.D. Bablyak


The article presents mutual connection between presence of some demographic features, risk factors, comorbidities variants, hemodynamic parameters and development and formation of resistant arterial hypertension. There are presented several examples of the existing prognostic and diagnostic scales that widely used in different medical areas (neurology, cardiology, endocrinology) for the same purpose. Having analyzed information obtained from the modern international trials and personal clinical experience we tried to create prognostication scale for the resistant arterial hypertension development in patients of both sexes of elderly (60–74 years old) and senile (75–89 years old) age. Four prognostication groups were defined in connection with the particular disease development as well as the features of the scale application in clinical practice are considered evidenced from the treatment of 2 patients.


resistant arterial hypertension in elderly persons; causes and diagnostic challenges; prognostic scale


Fagard R.H. Resistant hypertension // Heart. — 2012. — Vol. 98. — P. 254-261.

Moser M., Setaro J.F. Resistant Hypertension // N. Engl. J. Med. — 2006. — Vol. 355. — P. 385-92.

Persell S.D. Prevalence of resistant hypertension in the United States, 2003–2008 // Hypertension. — 2011. — Vol. 57. — P. 1076-1080.

Calhoun A.D., Jones D., Textor S. et al. Resistant Hypertension: Diagnosis, Evaluation, and Treatment // Hypertension. — 2008. — Vol. 51. — P. 1403-1419.

Weber M.A., Shiffrin E.L., White W.B. et al. Практичні клінічні рекомендації щодо лікування артеріальної гіпертензії в суспільстві // Артериальная гипертензия. — 2014. — № 2(34). — С. 75-92.

Mancia G., Fagard R., Narkiewicz K. et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension // J. Hypertens. — 2013. — Vol. 31(7). — P. 1281-1357.

Johnston S.C., Rothwell P.M., Nguyen-Huynh M.N. et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack // Lancet. — 2007. — Vol. 369. — P. 283-92.

Surgery, Camm A.J., Kirchhof P., Lip G.Y. et al. European Heart Rhythm Association; European Association for Cardio-Thoracic. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) // Eur. Heart J. — 2010. — Vol. 31. — P. 2369-2429.

Patel A., MacMahon S., Chalmers J. et al. Effects of a fixed combination of perindopril and indapamide on macrovascular outcomes in patients with type 2 diabetes mellitus (the ­ADVANCE trial): a randomized controlled trial // Lancet. — 2007. — Vol. 370. — P. 829-840.

Сиренко Ю.Н., Радченко А.Д., Слащева Т.Г. Стратификация риска пациентов с артериальной гипертензией и сахарным диабетом ІІ типа: результаты украинского многоцентрового обсервационного исследования СТАТУС // Артериальная гипертензия. — 2014. — № 2(34). — С. 9-19.

Copyright (c) 2016 HYPERTENSION

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.


© Publishing House Zaslavsky, 1997-2019


   Seo анализ сайта